Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells

Journal of Experimental Medicine

Volumn 188, Issue 3, 1998, Pages 439-450

  Krosl, Gorazd ^a   He, Gang ^a,b   Lefrancois, Martin ^a,b   Charron, Frédéric ^a,d   Roméo, Paul Henri ^e   Jolicoeur, Paul ^a,b   Kirsch, Ilan R ^c   Nemer, Mona ^a,b   Hoang, Trang ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

Apoptosis; c kit; SCL; Steel factor; TAL1

Indexed keywords

STEEL FACTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; ONCOGENE C KIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW CELLS; CELL SURVIVAL; DNA-BINDING PROTEINS; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0032479872     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.3.439     Document Type: Article

References (67)

1. Aplan, P.D., D.P. Lombardi, A.M. Ginsberg, J. Cossman, V.L. Bertness, and I.R. Kirsch. 1990. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science. 250:1426-1429.
2. Aplan, P.D., S.C. Raimondi, and I.R. Kirsch. 1992. Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia. J. Exp. Med. 176: 1303-1310.
3. Begley, G.G., P.D. Aplan, M.P. Davey, K. Nakahara, K. Tchorz, J. Kurtzberg, M.S. Hershfield, B.F. Haynes, D.I. Cohen, T.A. Waldmann, and I.R. Kirsch. 1989. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc. Natl. Acad. Sci. USA. 86:2031-2035.
4. Bernard, O., P. Guglielmi, P. Jonveaux, D. Cherif, S. Gisselbrecht, M. Mauchauffe, R. Berger, C.J. Larsen, and D. Mathieu-Mahul. 1990. Two distinct mechanisms for the SCL gene activation in the t(1; 14) translocation of T-cell leukemias. Genes Chromosomes Cancer. 1:194-208.
5. Chen, Q., J.T. Cheng, L.H. Tasi, N. Schneider, G. Buchanan, A. Carroll, W. Grist, B. Ozanne, M.J. Siciliano, and R. Baer. 1990. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO (Eur. Mol. Biol. Organ.) J. 9:415-424.
6. Finger, L.R., J. Kagan, G. Christopher, J. Kurtzberg, M.S. Hershfield, P.C. Nowell, and C.M. Croce. 1989. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc. Natl. Acad. Sci. USA. 86: 5039-5043.
7. Hsu, H.L., I. Wadman, J.T. Tsan, and R. Baer. 1994. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc. Natl. Acad. Sci. USA. 91:5947-5951.
8. Brady, G., F. Billia, J. Knox, T. Hoang, I.R. Kirsch, E.B. Voura, R.G. Hawley, R. Cumming, M. Buchwald, K. Siminovitch, et al. 1995. Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr. Biol. 5:909-922.
9. Hoang, T., E. Paradis, G. Brady, F. Billia, K. Nakahara, N.N. Iscove, and I.R. Kirsch. 1996. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood. 87:102-111.
10. Pulford, K., N. Lecointe, K. Leroy-Viard, M. Jones. D. Mathieu-Mahul, and D.Y. Mason. 1995. Expression of TAL-1 proteins in human tissues. Blood. 85:675-684.
11. Mouthon, M.A., O. Bernard, M.T. Mitjavila, P.H. Romeo, W. Vainchenker, and D. Mathieu-Mahul. 1993. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood. 81:647-655.
12. Aplan, F.D., K. Nakahara, S.H. Orkin, and I.R. Kirsch. 1992. The SCL gene product: a positive regulator of erythroid differentiation. EMBO (Eur. Mol. Biol. Organ.) J. 11: 4073-4081.
13. Begley, C.G., P.D. Aplan, S.M. Denning, B.F. Haynes, T.A. Waldmann, and I.R. Kirsch. 1989. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl. Acad. Sci. USA. 86:10128-10132.
14. Green, A.R., T. Lints, J. Visvader, R. Harvey, and C.G. Begley. 1992. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Oncogene. 7:653-660.
15. Green, A.R., E. Salvaris, and C.G. Begley. 1991. Erythroid expression of the 'helix-loop-helix' gene, SCL. Oncogene. 6: 475-479.
16. Miller, B.A., J. Floras, J.Y. Cheung, D.M. Wojchowski, L. Bell, C.G. Begley, N.J. Elwood, J. Kreider, and C. Christian. 1994. Steel factor affects SCL expression during normal erythroid differentiation. Blood. 84:2971-2976.
17. Robb, L., I. Lyons, R. Li, L. Hartley, F. Kontgen, R.P. Harvey, D. Metcalf, and C.G. Begley. 1995. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA. 92:7075-7079.
18. Shivdasani, R.A., E.L. Mayer, and S.H. Orkin. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 373:432-434.
19. Porcher, C., W. Swat, K. Rockwell, Y. Fujiwara, F.W. Alt, and S.H. Orkin. 1996. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:47-57.
20. Robb, L., N.J. Elwood, A.G. Elefanty, F. Kontgen, R.L. Li, L.D. Barnett, and C.G. Begley. 1996. The SCL gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO (Eur. Mol. Biol. Organ.) J. 15:4123-4129.
21. Hsu, H.L., L. Huang, J.T. Tsan, W. Funk, W.E. Wright, J.S. Hu, R.E. Kingston, and R. Baer. 1994. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol. Cell. Biol. 14:1256-1265.
22. Valge-Archer, V.E., H. Osada, A.J. Warren, A. Forster, J. Li, R. Baer, and T.H. Rabbitts. 1994. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc. Natl. Acad. Sci. USA. 91:8617-8621.
23. Wadman, I., J. Li, R.O. Bash, A. Forster, H. Osada, T.H. Rabbitts, and R. Baer. 1994. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO (Eur. Mol. Biol. Organ.) J. 13:4831-4839.
24. Wadman, I.A., H. Osada, C.G. Grütz, A.D. Agulnick, H. Westphal, A. Forster, and T.H. Rabbitts. 1997. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the Tal1, E47, GATA-1 and LDB1/NLI proteins. EMBO (Eur. Mol. Biol. Organ.) J. 16:3145-3157.
25. Warren, A.J., W.H. Colledge, M.B. Carlton, M.J. Evans, A.J. Smith, and T.H. Rabbitts. 1994. The oncogemc cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell. 78:45-57.
26. Tsai, S.F., D.I. Martin, L.I. Zon, A.D. D'Andrea, G.G. Wong, and S.H. Orkin. 1989. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature. 339:446-451.
27. Ono, Y., N. Fukuhara, and O. Yoshie. 1997. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J. Biol. Chem. 272:4576-4581.
28. Caceres-Cortes, J., D. Rajotte, J. Dumouchel, P. Haddad, and T. Hoang. 1994. Product of the steel locus suppresses apoptosis in hemopoietic cells. Comparison with pathways activated by granulocyte macrophage colony-stimulating factor. J. Biol. Chem. 269:12084-12091.
29. + antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and interleukin-3. J. Biol. Chem. 267:9980-9987.
30. Williams, G.T., C.A. Smith, E. Spooncer, T.M. Dexter, and D.R. Taylor. 1990. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature. 343: 76-79.
31. Chabot, B., D.A. Stephenson, V.M. Chapman, P. Besmer, and A. Bernstein. 1988. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 335:87-89.
32. Abrahamson, J.L., J.M. Lee, and A. Bernstein. 1995. Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor. Mol. Cell. Biol. 15:6953-6960.
33. Copeland, N.G., D.J. Gilbert, B.C. Cho, P.J. Donovan, N.A. Jenkins, D. Cosman, D. Anderson, S.D. Lyman, and D.E. Williams. 1990. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell. 63:175-183.
34. Fleischman, R.A. 1993. From white spots to stem cells: the role of the Kit receptor in mammalian development. Trends Genet. 9:285-290.
35. Russel, E.S. 1979. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 20:357-459.
36. Li, C.L., and G.R. Johnson. 1994. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood. 84:408-414.
37. Godfrey, D.I., A. Zlotnik, and T. Suda. 1992. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J. Immunol. 149:2281-2283.
38. Moll, J., H. Eibel, P. Schmid, G. Sansig, F. Botteri, R. Palacios, and H. Van der Putten. 1992. Thymic hyperplasia in transgenic mice caused by immortal epithelial cells expressing c-kit ligand. Eur. J. Immunol. 22:1587-1594.
39. Palacios, R., and S. Nishikawa. 1992. Developmentally regulated cell surface expression and function of c-kit receptor during lymphocyte ontogeny in the embryo and adult mice. Development (Camb.). 115:1133-1147.
40. Kitamura, T., T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y.F. Piao, K. Miyazono, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 orerythropoietin. J. Cell. Physiol. 140:323-334.
41. Rodriguez, C., C. Lacasse, and T. Hoang. 1996. Interleukin-1 beta suppresses apoptosis in CD34 positive bone marrow cells through activation of the type I IL-1 receptor. J. Cell. Physiol. 166:387-396.
42. Leroy-Viard, K., M.A. Vinit, N. Lecointe, H. Jouault, U. Hibner, P.H. Roméo, and D. Mathieu-Mahul. 1995. Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO (Eur. Mol. Biol. Organ.) J. 14:2341-2349.
43. Hawley, R.G., A.Z. Fong, M. Lu, and T.S. Hawley. 1994. The Hox-11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. Oncogene. 9: 1-12.
44. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
45. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156-159.
46. Tso, J.Y., X.H. Sun, T.H. Kao, K.S. Reece, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
47. Durocher, D., C.Y. Chen, A. Ardati, R.J. Schwartz, and M. Nemer. 1996. The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol. Cell. Biol. 16:4648-4655.
48. Kelliher, M.A., D.C. Seldin, and P. Leder. 1996. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIa. EMBO (Eur. Mol. Biol. Organ.) J. 15:5160-5166.
49. Tsujimura, T., E. Morii, M. Nozaki, K. Hashimoto, Y. Monyama, T. Takebayashi, T. Kondo, Y. Kanakura, and Y. Kitamura. 1996. Involvement of transcriptional factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Blood. 88:1223-1233.
50. Therrien, M., and J. Droum. 1993. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol. Cell. Biol. 13:2342-2353.
51. Koopman, G., C.P. Reutelingsperger, G.A. Kuijten, R.M. Keehnen, S.T. Pals, and M.H. van Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1415-1420.
52. Martin, S.J., C.P. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C. van Schie, D.M. LaFace, and D.R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545-1556.
53. Green, A.R., E. DeLuca, and C.G. Begley. 1991. Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. EMBO (Eur. Mol. Biol. Organ.) J. 10:4153-4158.
54. Ohashi, H., R. Kameda, M. Nishikawa, M. Kawagishi, and Y.C. Liu. 1994. The c-kit receptor transduces the stem cell factor-triggered growth signal in murine interleukin-3-dependent cell line. Cytotechnology. 16:27-35.
55. Nelson, B.H., J.D. Lord, and P.D. Greenberg. 1994. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature. 369:333-336.
56. Elefanty, A.G., L. Robb, R. Birner, and C.G. Begley. 1997. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. Blood. 90: 1435-1447.
57. Linette, G.P., J.L. Hess, C.L. Sentman, and S.J. Korsmeyer. 1995. Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice. Blood. 86:1255-1260.
58. Robb, L., J.E. Rasko, M.L. Bath, A. Strasser, and C.G. Begley. 1995. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene. 10:205-209.
59. Larson, R.C., I. Lavenir, T.A. Larson, R. Baer, A.J. Warren, I. Wadman, K. Nottage, and T.H. Rabbits. 1996. Protein dimenzation between Lmo2 (Rbtn2) and Tall alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 15:1021-1027.
60. Wolf, S.S., and A. Cohen. 1992. Expression of cytokines and their receptors by human thymocytes and thymic stromal cells. Immunology. 77:362-368.
61. Rodewald, H.R., K. Kretzschmar, W. Swat, and S. Takeda. 1995. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity. 3:313-319.
62. Elwood, N.J., and C.G. Begley. 1995. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia. Cell Growth Differ. 6:19-25.
63. Bishop, J.M. 1991. Molecular themes in oncogenesis. Cell. 64:235-248.
64. Linette, G.F., and S.J. Korsmeyer. 1994. Differentiation and cell death: lessons from the immune system. Curr. Opin. Cell. Biol. 6:809-815.
65. Pevny, L., C.S. Lin, V. D'Agati, M.G. Simon, S.H. Orkin, and F. Costantini. 1995. Development of hematopoietic cells lacking transcription factor GATA-1. Development (Camb.). 121:163-172.
66. Weiss, M.J., and S.H. Orkin. 1995. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl. Acad. Sci. USA. 92:9623-9627.
67. Grépin, C., G. Nemer, and M. Nemer. 1997. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcriptional factor. Development (Camb.). 124: 2387-2395.